These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 32704404)
1. Medina-Ornelas S; García-Perez F; Estrada-Lobato E; Ochoa-Carrillo F Am J Nucl Med Mol Imaging; 2020; 10(3):135-142. PubMed ID: 32704404 [TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings. Arslan E; Ergül N; Beyhan E; Erol Fenercioglu Ö; Sahin R; Cin M; Battal Havare S; Can Trabulus FD; Mermut Ö; Akbas S; Fikret Çermik T Nucl Med Commun; 2023 Apr; 44(4):284-290. PubMed ID: 36756767 [TBL] [Abstract][Full Text] [Related]
4. Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma. Mushtaq A; Lawal IO; Muzahir S; Friend SC; Bhave M; Meisel JL; Torres MA; Styblo TM; Graham CL; Kalinsky K; Switchenko J; Ulaner GA; Schuster DM Eur J Nucl Med Mol Imaging; 2024 Nov; 51(13):4073-4082. PubMed ID: 38976035 [TBL] [Abstract][Full Text] [Related]
5. von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806 [TBL] [Abstract][Full Text] [Related]
6. How accurate is Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneous uptake of Hu Y; Wang P; Dai W BMC Pulm Med; 2023 Mar; 23(1):73. PubMed ID: 36882747 [TBL] [Abstract][Full Text] [Related]
8. Exploratory analysis of 64 CuCl 2 PET-CT imaging in carcinoma prostate and its comparison with 68 Ga-PSMA-11 and 18 F-FDG PET-CT. Nazar AK; Kalshetty A; Chakravarty R; Chakraborty S; Basu S Nucl Med Commun; 2023 Oct; 44(10):910-923. PubMed ID: 37578310 [TBL] [Abstract][Full Text] [Related]
9. Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT. Lütje S; Gomez B; Cohnen J; Umutlu L; Gotthardt M; Poeppel TD; Bockisch A; Rosenbaum-Krumme S Clin Nucl Med; 2017 Jan; 42(1):20-25. PubMed ID: 27846003 [TBL] [Abstract][Full Text] [Related]
16. Comparison of [ Uprimny C; Svirydenka A; Fritz J; Kroiss AS; Nilica B; Decristoforo C; Haubner R; von Guggenberg E; Buxbaum S; Horninger W; Virgolini IJ Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1873-1883. PubMed ID: 29766246 [TBL] [Abstract][Full Text] [Related]
17. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients. Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731 [TBL] [Abstract][Full Text] [Related]
18. The diagnostic accuracy of Rajwa P; Heidenreich J; Drzezga A; Schmidt M; Shariat SF; Heidenreich A Prostate; 2024 Jan; 84(1):74-78. PubMed ID: 37750292 [TBL] [Abstract][Full Text] [Related]
20. Impact of uptake time on image quality of [ van der Sar ECA; Viol SLM; Braat AJAT; van Rooij R; Lam MGEH; de Jong HWAM; de Keizer B Med Phys; 2023 Dec; 50(12):7619-7628. PubMed ID: 37093883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]